Michael Egan

Cooley advised 1WorldSync, a leader in product content orchestration, on its acquisition by Syndigo, creating a $3.5 billion+ enterprise backed by Summit Partners, TJC LP and Battery Ventures.

Cooley advised MapLight Therapeutics, a clinical-stage biopharmaceutical company developing targeted, novel therapies for patients with central nervous system disorders, on its oversubscribed $372.5 million Series D financing.

Cooley represented Beta Bionics, a pioneering leader in the development of advanced diabetes management solutions, in its $234.6 million initial public offering and concurrent $17 million private placement.

Cooley advised Avid Bioservices (Nasdaq: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, on its definitive merger agreement to be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners in an all-cash transaction valued at approximately $1.1 billion.

Cooley advised Cents, the top all-in-one business management platform powering garment care small- and medium-sized businesses (SMBs), on its $40 million Series B financing, as well as its acquisition of Laundroworks, a hardware-based payments system powering how consumers pay for laundry at laundromats and shared laundry rooms within multifamily buildings, hotels, universities and more.